Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system

• Auteurs principaux: Wenfang Sun (Auteur), Yali Li (Auteur), Binbin Xia (Auteur), Jing Chen (Auteur), Yang Liu (Auteur), Jingyao Pang (Auteur), Fang Liu (Auteur), Hua Cheng (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Anti-Calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) have shown significant efficacy in preventing migraine. However, there have been limited reports of adverse events (AEs) after marketing, particularly for eptinezumab launched in 2020. The study aimed to mine and...